ORKA insider notice: 22,206 common shares listed

ORKA reported proposed sales of common stock by insiders under multiple mechanisms.

Rhea-AI Filing Summary

ORKA reported proposed sales of common stock by insiders under multiple mechanisms. The notice lists 19,749 shares from an exercise of stock options dated 05/18/2026, 1,758 shares from the Employee Stock Purchase Plan dated 12/08/2025, and 699 shares issuable upon Restricted Stock Units dated 03/14/2026.

The filing also records a prior sale of 395 shares by Arjun Agarwal on 03/16/2026 for $16,313.50.

Key Figures

Option exercise shares: 19,749 shares ESPP shares: 1,758 shares RSU shares: 699 shares +2 more

5 metrics

Option exercise shares 19,749 shares Exercise of Stock Options dated 05/18/2026

ESPP shares 1,758 shares Employee Stock Purchase Plan dated 12/08/2025

RSU shares 699 shares Restricted Stock Units dated 03/14/2026

Reported past sale 395 shares Sold by Arjun Agarwal on 03/16/2026 for $16,313.50

Aggregate listed here 22,206 shares Sum of listed proposed shares in the filing (19,749 + 1,758 + 699)

Key Terms

Form 144, Restricted Stock Units, Employee Stock Purchase Plan, Exercise of Stock Options

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | | | 699 | 03/14/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Employee Stock Purchase Plan financial

"Employee Stock Purchase Plan | Issuer | | | 1758 | 12/08/2025"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | | | 19749 | 05/18/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ORKA's Form 144 disclose about shares being sold?

The Form 144 lists proposed sales of 19,749 shares from an option exercise, 1,758 via the Employee Stock Purchase Plan, and 699 from restricted stock units, each with the dates shown in the filing.

Who sold shares recently for ORKA according to the filing?

The filing records a sale by Arjun Agarwal of 395 common shares on 03/16/2026 for $16,313.50, shown in the "Securities Sold During The Past 3 Months" section.

Are the transactions listed in the Form 144 completed or proposed for ORKA?

The Form 144 lists proposed sales tied to specific grant or issuance dates for options, ESPP, and RSUs; it also reports a completed sale of 395 shares on 03/16/2026 by Arjun Agarwal as recorded.

Which securities types are referenced in the ORKA Form 144?

The filing references Common stock in three categories: Exercise of Stock Options (19,749), Employee Stock Purchase Plan (1,758), and Restricted Stock Units (699), with dates shown for each.

What dates are associated with the listed securities in ORKA's filing?

Dates shown: 05/18/2026 for the option exercise related shares, 12/08/2025 for ESPP shares, and 03/14/2026 for RSU issuances; the prior sale occurred on 03/16/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:34 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002033974
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oruka Therapeutics, Inc.
SEC File Number	000-22873
Address of Issuer	855 Oak Grove Avenue Suite 100 Menlo Park CALIFORNIA 94025
Phone	6506067910
Name of Person for Whose Account the Securities are To Be Sold	ARJUN AGARWAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22206	1375217.58	60312101	05/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/18/2026	Exercise of Stock Options	Issuer			19749	05/18/2026	Cash
Common	12/08/2025	Employee Stock Purchase Plan	Issuer			1758	12/08/2025	Cash
Common	03/14/2026	Restricted Stock Units	Issuer			699	03/14/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ARJUN AGARWAL 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	03/16/2026	395	16313.50

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	05/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Arjun Kumar Agarwal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)